Federated Hermes’s Centessa Pharmaceuticals CNTA Stock Holding History

Federated Hermes’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,049,439	Closed	-$81.4M	–	2058
2026 Q1	$81.4M	Sell	2,049,439 -292,700	-12%	-$7.49M	0.13%	180
2025 Q4	$58.6M	Buy	2,342,139 +592,489	+34%	+$15M	0.1%	239
2025 Q3	$42.4M	Buy	+1,749,650	New	+$31.1M	0.07%	301

Federated Hermes's CNTA Position: Q2 2026 in Review

Federated Hermes sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 2,049,439 shares — an estimated $81.4M sold.

Federated Hermes first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $81.4M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Federated Hermes reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Federated Hermes sold 2,049,439 Centessa Pharmaceuticals shares in Q2 2026, an estimated $81.4M.
Federated Hermes first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Federated Hermes's Centessa Pharmaceuticals position peaked at $81.4M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.